Skip to main content

Table 7 Baseline characteristics of the UA patients with erosions (≥2 erosive joints) that did and did not progress to RA within one year

From: The prognostic value of baseline erosions in undifferentiated arthritis

Characteristic

Total

(n = 83)

Developed RA

(n = 44)

Did not develop RA

(n = 39)

P

Female gender n (%)

44 (53)

26 (53.8)

18 (46.2)

0.2

Age in years (Mean ± SD)

61.5 ± 16

60.7 ± 16.4

62.5 ± 15.6

0.6

Symptom duration at inclusion in months (Mean ± SD)

6.5 ± 6.3

7.1 ± 7.4

5.7 ± 4.8

0.9

Morning stiffness (Mean ± SD)

74.9 ± 100.5

92.2 ± 114.4

55.4 ± 78.9

0.04

Tender joint count (Mean ± SD)

6.9 ± 5.8

9 ± 6.7

4.6 ± 3.7

<0.001

Swollen joint count (Mean ± SD)

4.7 ± 4

6 ± 4

3.2 ± 3.4

<0.001

HAQ score (Mean ± SD)

0.89 ± 0.74

0.9 ± 0.73

0.87 ± 0.75

0.9

ESR (mm/hr) (Mean ± SD)

34.7 ± 24.7

41.3 ± 24

27.2 ± 23.6

0.004

CRP (mg/L) (Mean ± SD)

27.8 ± 31.4

33.4 ± 30.4

21.5 ± 31.7

0.005

RF positivity n (%)

31 (37.3)

22 (50)

9 (23.1)

0.01

ACPA positivity n (%)

25 (32.5)

20 (51.3)

5 (13.2)

< 0.001

SHS erosion score (mean ± SD)

4.2 ± 3.4

4.7 ± 4.3

3.7 ± 1.8

0.4

  1. ACPA = anticyclic citrullinated peptide antibody; CRP = C-reactive protein; ESR = erythrocytic sedimentation rate; HAQ = health assessment questionnaire; RA = rheumatoid arthritis; SD = standard deviation; SHS = Sharp/van der Heijde scoring; UA = undifferentiated arthritis.
  2. Morning stiffness score on a 100-mm visual analogue score.